Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 16 November, 2012

Curanum Ag

EANS-Adhoc: CURANUM AG / Capital Increase Compl...

PR Newswire/euro adhoc/
EANS-Adhoc: CURANUM AG / Capital Increase Completed
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc 
with the aim of a Europe-wide distribution. The issuer is solely responsible for
the content of this announcement.

16.11.2012

On November 16, 2012 Curanum AG's capital increase, passed by a resolution of
the Management Board on September 27, 2012 and approved by the Supervisory
Board, was entered in the Commercial Register. Curanum AG's capital stock has
thus increased by EUR3,315,000, from EUR39,132,000 to EUR42,507,000, with
42,507,000 bearer shares each representing a proportionate interest in the
capital stock of EUR1.00 per share. The capital increase has thus been
successfully completed.

The new shares will be issued to subscribers probably by the end of calendar
week 47.

Curanum AG

Munich, November 16, 2012

The Management Board



Further inquiry note:
Frau Caroline Lutz
Unternehmensentwicklung
Tel: 089/ 24 20 65-0
E-Mail: [email protected]

issuer:      CURANUM AG
             Engelbertstraße 23-25
             D-81241 München
phone:       +49 (0)89 242065 0
FAX:         +49 (0) 89 242065 10
mail:        [email protected]
WWW:         http://www.curanum.de
sector:      Healthcare Providers
ISIN:        DE0005240709
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated
             dealing: München, regulated dealing/prime standard: Frankfurt 
language:   English
        
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication.

a d v e r t i s e m e n t